ALAB Astera Labs, Inc. | US04626A1034
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 2.235.197.230 | 1.549.258.240 | 44.28% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 4,53 | 3,01 | 50.34% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 22 | 24 | 8.33% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |